(Q53051361)

English

Change in quality of life in patients with relapsing-remitting multiple sclerosis over 2 years in relation to other clinical parameters: results from a trial of intramuscular interferon {beta}-1a.

scientific article published on 7 February 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

10 May 2018

http://europepmc.org/abstract/MED/21300736

Change in quality of life in patients with relapsing-remitting multiple sclerosis over 2 years in relation to other clinical parameters: results from a trial of intramuscular interferon {beta}-1a. (English)

1 reference

Europe PubMed Central

10 May 2018

http://europepmc.org/abstract/MED/21300736

relapsing-remitting multiple sclerosis

0 references

multiple sclerosis

0 references

quality of life

1 reference

based on heuristic

inferred from title

Bianca Weinstock-Guttman

2

object named as

B Weinstock-Guttman

1 reference

Europe PubMed Central

10 May 2018

http://europepmc.org/abstract/MED/21300736

author name string

D M Miller

1

1 reference

Europe PubMed Central

10 May 2018

http://europepmc.org/abstract/MED/21300736

D Bourdette

3

1 reference

Europe PubMed Central

10 May 2018

http://europepmc.org/abstract/MED/21300736

X You

4

1 reference

Europe PubMed Central

10 May 2018

http://europepmc.org/abstract/MED/21300736

P Foulds

5

1 reference

Europe PubMed Central

10 May 2018

http://europepmc.org/abstract/MED/21300736

R A Rudick

6

1 reference

Europe PubMed Central

10 May 2018

http://europepmc.org/abstract/MED/21300736

publication date

7 February 2011

1 reference

Europe PubMed Central

10 May 2018

http://europepmc.org/abstract/MED/21300736

Multiple Sclerosis Journal

1 reference

Europe PubMed Central

10 May 2018

http://europepmc.org/abstract/MED/21300736

17

1 reference

Europe PubMed Central

10 May 2018

http://europepmc.org/abstract/MED/21300736

6

1 reference

Europe PubMed Central

10 May 2018

http://europepmc.org/abstract/MED/21300736

734-742

1 reference

Europe PubMed Central

10 May 2018

http://europepmc.org/abstract/MED/21300736

Multiple sclerosis

1 reference

https://api.crossref.org/works/10.1177%2F1352458510397221

21 January 2018

Health-related quality of life in multiple sclerosis: effects of natalizumab

1 reference

https://api.crossref.org/works/10.1177%2F1352458510397221

21 January 2018

Quality of life in multiple sclerosis: measuring the disease effects more broadly.

1 reference

https://api.crossref.org/works/10.1177%2F1352458510397221

21 January 2018

A comparison of health-related quality of life in patients with epilepsy, diabetes and multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1177%2F1352458510397221

21 January 2018

Using the SF-36 measure to compare the health impact of multiple sclerosis and Parkinson's disease with normal population health profiles

1 reference

https://api.crossref.org/works/10.1177%2F1352458510397221

21 January 2018

Quality of life in multiple sclerosis: influence of interferon-beta1 a (Avonex) treatment.

1 reference

https://api.crossref.org/works/10.1177%2F1352458510397221

21 January 2018

A longitudinal study of quality of life and side effects in patients with multiple sclerosis treated with interferon beta-1a

1 reference

https://api.crossref.org/works/10.1177%2F1352458510397221

21 January 2018

Influence of Interferon beta treatment on quality of life in multiple sclerosis patients

1 reference

https://api.crossref.org/works/10.1177%2F1352458510397221

21 January 2018

Disease-specific quality of life in multiple sclerosis: the effect of disease modifying treatment.

1 reference

https://api.crossref.org/works/10.1177%2F1352458510397221

21 January 2018

Interferon-beta1b in the treatment of secondary progressive MS: impact on quality of life.

1 reference

https://api.crossref.org/works/10.1177%2F1352458510397221

21 January 2018

Factors that predict health-related quality of life in patients with relapsing-remitting multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1177%2F1352458510397221

21 January 2018

Low-contrast letter acuity testing captures visual dysfunction in patients with multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1177%2F1352458510397221

21 January 2018

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

1 reference

https://api.crossref.org/works/10.1177%2F1352458510397221

21 January 2018

The Sickness Impact Profile as a Tool to Evaluate Functional Outcome in Trauma Patients

1 reference

https://api.crossref.org/works/10.1177%2F1352458510397221

21 January 2018

Outcomes assessment in multiple sclerosis clinical trials: a critical analysis.

1 reference

https://api.crossref.org/works/10.1177%2F1352458510397221

21 January 2018

A health-related quality of life measure for multiple sclerosis

1 reference

https://api.crossref.org/works/10.1177%2F1352458510397221

21 January 2018

A preliminary report on a skills-based telephone-administered peer support programme for patients with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1177%2F1352458510397221

21 January 2018

The impact of outpatient rehabilitation on quality of life in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1177%2F1352458510397221

21 January 2018

A randomized group intervention trial to enhance mood and self-efficacy in people with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1177%2F1352458510397221

21 January 2018

Review of intervention studies on depression in persons with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1177%2F1352458510397221

21 January 2018

Psychosocial interventions in people with multiple sclerosis: a review

1 reference

https://api.crossref.org/works/10.1177%2F1352458510397221

21 January 2018

Active music therapy in the treatment of multiple sclerosis patients: a matched control study.

1 reference

https://api.crossref.org/works/10.1177%2F1352458510397221

21 January 2018

Variables associated with attendance at, and the perceived helpfulness of, meetings for people with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1177%2F1352458510397221

21 January 2018

Identifiers

10.1177/1352458510397221

1 reference

Europe PubMed Central

10 May 2018

http://europepmc.org/abstract/MED/21300736

1 reference

Europe PubMed Central

10 May 2018

http://europepmc.org/abstract/MED/21300736

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53051361&oldid=1819826681"